Stay updated on Pembrolizumab for HNSCC Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HNSCC Residual Disease Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, signaling a minor platform/template update to the page. No changes to study data or content are introduced.
    Difference
    0.1%
    Check dated 2026-05-14T23:23:33.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    A new page revision tag, v3.5.3, was added and the previous revision tag, v3.5.2, was removed. This reflects a metadata update to the page rather than a change to study content or results.
    Difference
    0.1%
    Check dated 2026-04-30T17:19:03.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now shown in the page footer, replacing Revision: v3.5.0. No changes to study content or data are indicated.
    Difference
    0.1%
    Check dated 2026-04-16T11:09:55.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added the disease term 'Squamous cell carcinoma of the head and neck' and a Resources entry for Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T05:35:51.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed. This appears to be a technical site update with no changes to trial content.
    Difference
    0.1%
    Check dated 2026-03-18T20:19:27.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:23:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HNSCC Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.